neurology

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

Closeup of X-ray photography of human brain

Biogen and Eisai Alzheimer's drug excites doctors, but not i...

Investors spooked after string of failures

News

PureTech to research Alzheimer's drugs based on 'brain drain...

US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain.

News

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

After years of delays Pfizer and Eli Lilly’s tanezumab non-opioid pain drug is edging closer to approval, after it met targets in an osteoarthritis trial.

News

Sunovion’s Parkinson’s disease drug is a step closer to appr...

The U.S.

News

Sarepta goes up, PTC goes down – DMD research sways the mark...

US biotech Sarepta's shares jumped by as much as 60% after a gene therapy produced dramatic results in three boys with the muscle wasting disease Duchenne muscular dystrophy (DMD).

Breakthrough migraine prevention treatment approved in Europ...

Biogen and Eisai Alzheimer's drug excites doctors, but not i...

PureTech to research Alzheimer's drugs based on 'brain drain...

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

Sunovion’s Parkinson’s disease drug is a step closer to appr...

Sarepta goes up, PTC goes down – DMD research sways the mark...

ADARx, Trex, and Retension take aim at IPOs

Discover a new era of healthcare panel engagement: Grounded ...

neurology

Editor's Picks